Haier Biomedical Centrifuges: Outstanding Performance Built on Reliability
Instrument.com.cn News — Haier Biomedical’s bench-top multifunctional refrigerated centrifuge LX-155T500R has earned the “Chinese Premium Instruments” title on the strength of its ability to solve the pain points of cell-room scenarios. While keeping the cost advantage of a domestic product, the unit delivers centrifugal performance and service responsiveness on a par with imported brands, offering a high cost-performance option for research and clinical sample processing.
The “Chinese Premium Instruments” program has been running since 2013, with twelve years of history so far. Over the years, the program has been dedicated to finding excellent instruments and brands to represent, using broad outreach to build awareness among users based on actual work needs, and establishing a monument to Chinese instruments in users’ minds in order to drive the healthy and rapid development of Chinese instruments. With this in mind, Instrument.com.cn has initiated the “Story Behind a Chinese Premium Instrument” article-invitation program. In this installment, we step inside Haier Biomedical and speak with Wang Heng, Product Manager of Haier Biomedical centrifuges, to explore the journey of a “Chinese Premium Instrument.”
Wang Heng, Product Manager of Haier Biomedical centrifuges
Q1: First, congratulations on your product being awarded the “Chinese Premium Instruments” title. Based on your many years’ experience in the scientific-instrument field, what qualities do you think make an instrument a true “good instrument”?
Thank you to the organizers and the users for the recognition of Haier Biomedical. In Haier Biomedical’s view, a true “good instrument” is not a cold stack of specifications, but a partner that can solve user pain points and safeguard research and clinical work. It must have independently controllable core technology and stable, reliable performance; it must understand users, not copy imported templates, and fit actual Chinese usage scenarios; and, most importantly, it must carry a sense of reverence for life—with safety and precision as prerequisites, protecting sample activity and experimental results. This is how Haier Biomedical puts “science and technology protecting life” into practice.
Q2: Please introduce in detail the product of your company that has been awarded the “Chinese Premium Instruments” title, and share the development process of this “Chinese Premium Instrument,” as well as its core technologies.
Bench-top multifunctional refrigerated centrifuge LX-155T500R
The selected bench-top multifunctional refrigerated centrifuge LX-155T500R was designed by Haier Biomedical entirely from real user scenarios. Three years ago, when we surveyed more than 100 hospitals, universities and pharmaceutical companies across the country, we found that both laboratory and cell-room users had been facing common pain points for a long time:
In the research laboratory, the centrifuge is a high-frequency device, and user pain points fall into two camps: imported brands—expensive, slow after-sales service, long waits for parts; domestic brands—good cost-effectiveness, but with room to improve in centrifugation results and timely response. A more practical problem is that, with different brands coming into the lab, laboratories often end up with centrifuges of all kinds crowding the room. And the biggest headaches are high vibration, loud noise and imprecise temperature control—after going to all the effort to extract nucleic acids and proteins, the result is poor consistency and no assurance of experimental quality.
If the laboratory pain points are mainly about balancing general performance and cost, cell-room users’ requirements are even more focused and demanding. The collection of live cells sets extremely high requirements on the equipment—cell yield and viability are the two core metrics, which translate into the requirements of low vibration and precise temperature control. Heavy vibration makes cells “suffer,” yield drops and losses mount, and batch-to-batch variation grows; imprecise temperature control lowers cell viability, so that after the next passage culture the cell count is visibly reduced. In the end, after users have painstakingly cultured their cells, the yield or viability may simply fail to meet standards—leaving them unable to collect the number needed and having to re-culture—wasting time and money.
Therefore, combining the refined appearance, stable centrifugation result and excellent operational reliability of imported brands with the price advantage and efficient service response of domestic equipment became an urgent user need—and Haier Biomedical’s R&D target.
In differentiated feature design, we focused on overcoming cell yield and viability challenges, raising the industry’s typical 80% to more than 90%, with viability close to 100%, substantially saving experimental cost. Adopting a PID algorithm with seamless scroll-winding technology, temperature-control precision reaches ±1 °C, guaranteeing sample stability. Twelve rotor types have been developed, compatible with everything from 0.2 mL PCR tubes to 500 mL centrifuge bottles, achieving “one machine, multiple uses.”
On safety, we built a “Fourfold Smart Safeguard”: rotor static identification automatically locks the maximum speed; a six-axis vibration sensor monitors anomalies in real time; a self-latching shock-resistant door lock does not pop open in case of abnormality; and each rotor carries an ID for life-cycle traceability. Together, these technologies ensure comprehensive leadership in performance, adaptability and safety—so that our centrifuges, on the foundation of a domestic price, are entirely comparable in quality to imported equipment.
“Chinese Premium Instruments” selection certificate
Q3: What do you see as the core reasons this product has won user recognition? To meet the standard of “a product is only truly good when users say it is” and earn broad user recognition, what specific measures has your company taken?
The core is simple: a product is only truly good when users say it is. Haier Biomedical has placed “user needs” at the top of the agenda from the very beginning of R&D. The team immersed itself in users’ laboratories, recording every operational pain point of inspection staff, researchers and pharmaceutical engineers. For example, for laboratories short on space we reduced the equipment footprint; for the inconvenience of operating with gloves on, we optimized the touch-screen buttons; for water-puddle corrosion in drainage troughs we added a water-puddle-prevention design. In addition, Haier Biomedical has built a nationwide multi-branch service network, with regular user follow-ups and customized solutions. Our centrifuges have truly delivered “imported quality at a domestic price,” and it is precisely for this reason that the product has genuinely won users’ hearts.
Q4: In which fields is your “Chinese Premium Instruments”-awarded product mainly applied? Which fields do you consider most promising, and will you prioritize them for expansion?
The bench-top multifunctional refrigerated centrifuge LX-155T500R is designed specifically for two scenarios, with features and performance precisely matched to needs. In research-laboratory scenarios it is suited to DNA/RNA extraction, plasmid purification, large-molecule protein separation, PCR sample preparation and more in universities, enterprises and research institutes; in cell-room scenarios it is dedicated to the handling of live cells such as mesenchymal stem cells, NK cells and tumor cells, providing precise temperature and speed control and protecting cell activity and yield.
Leveraging its “imported quality at a domestic price” cost-performance advantage, the LX-155T500R has already entered institutions including the Kunming Institute of Zoology, Chinese Academy of Sciences, the University of Science and Technology of China, Zhejiang University, Fudan University, Sichuan University, China Agricultural University, the China National Rice Research Institute, West China Hospital, the Children’s Hospital of Soochow University and the First Affiliated Hospital of Chongqing Medical University. Users are unanimous that this Haier Biomedical bench-top multifunctional refrigerated centrifuge has strong adaptability, stable operation and convenient operation, with high cell yield, and has substantially improved experimental efficiency and result reliability.
In the future, clinical diagnostics and biopharmaceuticals are key expansion directions for Haier Biomedical. As precision medicine and cell therapy develop, demand for centrifuge equipment in terms of traceability, stability and low-temperature performance is increasing—and our PID technology, smart-safeguard system and rotor-ID traceability precisely meet these requirements.
Q5: Following the principle “a product is only truly good when users say it is,” where do you see Chinese instruments excelling today, and where do they still need to improve? In the current environment, what do you see as the core competitiveness of Chinese instruments?
From dependence on imports, to domestic substitution, and now to setting the benchmark for Chinese instruments, the progress of domestic instruments is plain to see. In the current environment, only product solutions that truly understand user pain points, respond promptly to user needs, offer customization on demand and provide one-stop service can earn market recognition. In the future, Haier Biomedical will continue to put users at the center, using reliable products and attentive service to contribute Chinese strength to the life-science field—making sure every sample is precisely safeguarded, and that every experiment is more efficient and safer. This is the original intention behind our “good instrument” work.
About Haier Biomedical
Haier Biomedical is an important strategic deployment of Yingkang Life—Haier Group’s greater-health business segment—in the life-science industry. It listed on the Science and Technology Innovation Board (STAR Market) in 2019 (stock code: 688139) and in May 2026 received certification from Euromonitor as No. 1 in China’s own-brand sales of life-science laboratory equipment globally, and No. 1 in overseas sales of China’s own-brand life-science laboratory equipment (data scope: 2025 global sales of Chinese own-brand life-science laboratory equipment). The company aims to become a globally trusted world-class brand in the life-science industry, focusing on delivering the best user experience. It serves life-science users including biopharmaceutical enterprises and university research institutions, as well as medical and public-health users including hospitals, disease-control authorities, blood banks and grassroots public-health entities, providing digital, scenario-based integrated solutions across multiple industrial areas including low-temperature storage, smart research, smart medication and blood technologies. The company is restructuring core user scenarios in life-science R&D and medical services through AI + automation in depth, accelerating the application of AI in life science.
The company continues to strengthen its global business footprint, with products and solutions used in more than 160 countries and regions. Its ultra-low-temperature and constant-temperature production lines have achieved No. 1 share in multiple countries. The company maintains long-term, sustained partnerships with nearly 80 international organizations including the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF), and is a leading Chinese brand going abroad in the field of life-science laboratory equipment. Haier Biomedical is committed to staying at the forefront of green-development exploration: 34 of its models have received U.S. ENERGY STAR certification, and its Ultra Energy series ultra-low-temperature freezers occupy the top 8 spots on the ENERGY STAR ranking. In addition, the company has built an open, ecosystem-oriented industrial development model. Through long-term M&A integration practice it has developed its own “select / merge / complement / strengthen” M&A and operational-excellence system, continuously consolidating its core competitiveness as a globally leading integrated life-science tools and intelligent productivity platform provider.
About the Chinese Premium Instruments (国产好仪器) Program
For many years, the Instrument.com.cn “Chinese Premium Instruments” program has been committed to the principle that “a product is only truly good when users say it is.” Built on real long-term feedback from actual users, the program identifies outstanding Chinese instruments with excellent quality and stable performance through research, then promotes them on its users’ behalf, addressing the pain points of “difficult to build trust in, difficult to promote” Chinese instruments and helping the high-quality development of Chinese scientific instruments. Today the newly upgraded “Chinese Premium Instruments” program has set sail again, and more excellent Chinese-instrument manufacturers are welcome to apply.